⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SYRE News
Spyre Therapeutics, Inc. Common Stock
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
globenewswire.com
SYRE
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million
globenewswire.com
SYRE
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
globenewswire.com
SYRE
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants
globenewswire.com
SYRE
Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025
globenewswire.com
SYRE
Spyre Therapeutics Announces Grants of Inducement Awards
globenewswire.com
SYRE